This company seems to have been delisted
Reason: Acquired by Halozyme
Last recorded trade on: April 29, 2022
Source: https://www.prnewswire.com/news-releases/halozyme-completes-antares-pharma-acquisition-301553744.html
Reason: Acquired by Halozyme
Last recorded trade on: April 29, 2022
Source: https://www.prnewswire.com/news-releases/halozyme-completes-antares-pharma-acquisition-301553744.html
Antares Pharma
ATRS
4,74 €
Share price
0.00%
Change (1 day)
16.27%
Change (1 year)
Categories
Revenue for Antares Pharma (ATRS)
Revenue in 2021: €0.15 Billion
According to Antares Pharma's latest financial reports the company's current revenue (TTM 
) is €0.15 Billion. In 2021 the company made a revenue of €0.15 Billion an increase over the revenue in the year 2020 that were of €0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Antares Pharma from 1996 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 | €0.15 B | 22.98% |
| 2020 | €0.12 B | 20.78% |
| 2019 | €0.10 B | 94.9% |
| 2018 | €53.86 M | 16.58% |
| 2017 | €46.2 M | 4.39% |
| 2016 | €44.26 M | 14.38% |
| 2015 | €38.69 M | 72.28% |
| 2014 | €22.46 M | 28.53% |
| 2013 | €17.47 M | -8.67% |
| 2012 | €19.13 M | 37.17% |
| 2011 | €13.95 M | 28.39% |
| 2010 | €10.86 M | 54.24% |
| 2009 | €7.04 M | 46.82% |
| 2008 | €4.79 M | -27.95% |
| 2007 | €6.65 M | 84.07% |
| 2006 | €3.61 M | 91.86% |
| 2005 | €1.88 M | -18.98% |
| 2004 | €2.32 M | -27.49% |
| 2003 | €3.2 M | -5.23% |
| 2002 | €3.38 M | 14.21% |
| 2001 | €2.96 M | 75.52% |
| 2000 | €1.68 M | -42.75% |
| 1999 | €2.95 M | 26.57% |
| 1998 | €2.33 M | -25.99% |
| 1997 | €3.15 M | 0.68% |
| 1996 | €3.12 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | €0.57 B | 266.38% | 🇺🇸 USA |
 Becton Dickinson BDX | €17.68 B | 11,241.87% | 🇺🇸 USA |
 West Pharmaceutical WST | €2.45 B | 1,473.96% | 🇺🇸 USA |
 Retractable Technologies RVP | €28.6 M | -81.66% | 🇺🇸 USA |
 Pfizer PFE | €52.94 B | 33,850.60% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | €14.08 B | 8,930.77% | 🇮🇱 Israel |
 Johnson & Johnson JNJ | €75.71 B | 48,454.21% | 🇺🇸 USA |
 Eli Lilly LLY | €41.53 B | 26,534.78% | 🇺🇸 USA |